The qPCR Reagents Market size in Europe was valued at USD 0.45 billion in 2022 and estimated to be growing at a CAGR of 9.21%, to worth USD 0.70 billion by 2027.
A qPCR is also known as a real-time polymerase chain reaction, is a lab method of molecular biology that works via a polymerase chain reaction. QPCR screens the magnification of a specific DNA segment undergoing polymerase chain reaction. It can be applied in two variations, the semi-quantitative real-time polymerase chain reaction and quantitative real-time polymerase chain reaction.
Two common methods for detecting PCR in real-time PCR are non-specific fluorescent dyes that intercalate with any double-stranded DNA, and sequence-specific DNA probes consisting of oligonucleotides are labeled with a fluorescent reporter. The procedure is used for forensic, research, and diagnostic purposes. The term qPCR reagents market defines the market for reagents used in real-time PCR.
The rise of the qPCR Reagents is mainly driven by factors such as the rise inthe patient population for genetic disorders and infectious diseases, the rise in the geriatric population, and the advancements in technology related to the field. The other major factors boosting the growth are increasing public and private funding, grants, and investments for studies on PCR.
The market remains restricted by technical restrictions related to qPCR and the high costs associated with it.
This research report on the Europe qPCR reagents market has been segmented and sub-segmented into the following categories:
By Detection Method:
By Packaging Type:
By End User:
Companies playing a leading role in the European qPCR Reagents market are Thermo Fisher Scientific, Bio-Rad Laboratories, Qiagen N.V., F. Hoffmann-La Roche, Agilent Technologies Inc., Takara Bio, Affymetrix Inc., Promega Corporation, Sigma-Aldrich Corporation, and Quanta Biosciences.
Access the study in MULTIPLE FORMATS
Purchase options starting from $ 2000
Call us on: +1 888 702 9696 (U.S Toll Free)
Write to us: email@example.com